Moderate–severe asthma presents challenges in symptom control and exacerbation prevention and, despite Global Initiative for Asthma (GINA) recommendations favoring maintenance and reliever therapy (MART), its real-world adoption and implementation may vary

The “What About MART Posology” (WAMP) survey aimed to assess the knowledge, implementation, and adherence to MART among Italian HCPs and patients, hypothesizing that differences in understanding and prescribing practices can influence asthma management outcomes.

Pneumologists and allergologists recommend MART to their patients more than GPs, showing greater adherence to GINA recommendations.

While MART was widely implemented, differences in prescribing patterns and therapeutic choices suggest the need for continued efforts to support optimal asthma management strategies in clinical practice.